
Dae-Hee Kim
Ulsan Univ., Korea
L1-1. The Role of OPSYNVI® in PAH treatment goals : From Early risk reduction to Sustained low‑risk status
CV
Jung Hyun Choi
Pusan National Univ., Korea
L1-2. Clinical Efficacy of OPSYNVI® Compared with Monotherapy : Clinical evidence and Real-world practice in PAH

손정우
연세의대 심장내과
L2-1. Unlocking the potential of PAH management w/ Riociguat

Jung Hyun Choi
Pusan National Univ., Korea
L3-1. The First Activin Signal Inhibitor, Sotatercept

John Feenstra
The Wesley Hospital, Australia
P9-2. Paradigm Shift in PAH Treatment and Role of Sotatercept
CV
Soo Yong Lee
Pusan National Univ., Korea
P9-3. Sotatercept Position in Guidelines and How Does It Really Work

Jina Yeo
Gachon Univ., Korea
P9-4. Who Would Benefit from ASI / Sotatercept in Korea? (Deep dive into CTD-PAH)
CV
Mar.2007- Feb 2009 Postgraduate School, Seoul National University, Seoul, Korea(Ph.D. in Medical Science)
Mar.2002-Feb. 2004 Postgraduate School, Seoul National University, Seoul, Korea(Master of Medical Science)
Mar.1995 -Feb.1999 College of Medicine, Seoul National University, Seoul, Korea(M.D.)
Mar. 1993-Feb.1995 Premedical Course, College of Liberal Arts & ScienceSeoul National University, Seoul, Korea
Mar.1990- Feb.1993 Seoul Science High School, Seoul, Korea
Sep.2023-present Director of Pulmonary Hypertension & Venous Thrombosis Center, Asan Medical Center, Seoul, Korea
Sep.2021-present Professor in Cardiology Asan Medical Center, Ulsan college of medicine, Seoul, Korea
Mar.2020-present Director of Echocardiography Laboratory, Asan Medical Center, Seoul, Korea
Apr.2015- Aug.2021 Associate professor in Cardiology Asan Medical Center, Ulsan college of medicine, Seoul, Korea
Feb.2016-Feb.2018 Research fellow, Harvard medical school, Massachusetts General Hospital, Boston, USA
Mar.2010-Mar.2015 Assistant professor in Cardiology Asan Medical Center, Ulsan college of medicine, Seoul, Korea
Mar.2009-Feb.2010 Clinical Fellowship in echocardiography & cardiac imagingAsan Medical Center, Seoul, Korea
May.2007-Feb.2009 Clinical Fellowship in general cardiology, Seoul National University Hospital, Seoul, Korea
Apr.2004- Apr.2007 Public Health Doctor Ministry of Health & Welfare, Korea
Mar.2000-Feb.2004 Residency in Internal medicine Seoul National University Hospital, Seoul, Korea
Mar.1999-Feb.2000 Internship, Seoul National University Hospital, Seoul, Korea
Echocardiography
Cardiac CT imaging
Valvular heart disease
Hypertension
Pulmonary arterial hypertension
Ajou University, School of Medicine (MD)
Graduate School, Ulsan University (MS)
Graduate School, Ulsan University (PhD)
Asan Medical Center, Department of Internal Medicine (resident)
Asan Medical Center, Department of respiratory and critical care medicine (Clinical fellowship)
Asan Medical Center, Department of respiratory and critical care medicine (clinical assistant professor)
Asan Medical Center, Department of respiratory and critical care medicine (Associate professor)
Asan Medical Center, Department of respiratory and critical care medicine (Professor)
Chronic obstructive lung disease
Pulmonary hypertension
Pulmonary embolism
Cardiopulmoanry physiology
Lee B, Oh YM, Lee SW, Lee SD, Lee JS. Value of cardiopulmonary exercise testing in the assessment of symptoms and quality of life in Asian patients with chronic obstructive pulmonary disease. J Thorac Dis. 2023 Jul 31;15(7):3662-3672
Kim HC, Park JH, Song JM, Hwang JJ, Hong SB, Oh YM, Lee SD, Lee JS. Safety of Early Orthopedic Surgery in Patients With Intermediate/Low- Or Low-Risk Pulmonary Embolism. J Thorac Dis. 2020 Mar;12(3):232-239.
Hwang JJ, Shin SH, Kim YJ, Oh YM, Lee SD, Kim YH, Choi CW, Lee JS. Epidemiology of Antiphospholipid Syndrome in Korea: a Nationwide Population-based Study. Korean Med Sci. 2020 Feb 10;35(5):e35.
Lee JH, Hyun DG, Choi CM, Lee JC, Kim WS, Oh YM, Lee SD, Lee JS. A Retrospective Study on Efficacy and Safety of Rivaroxaban and Dalteparin for Long-Term Treatment of Venous Thromboembolism in Patients with Lung Cancer. Respiration. 2019; 98(3):203-211.
Oh DK, Song JM, Park DW, Oh SY, Ryu JS, Lee J, Lee SD, Lee JS. The effect of a multidisciplinary team on the implementation rates of major diagnostic and therapeutic procedures of chronic thromboembolic pulmonary hypertension. Heart Lung. 2019 Jan;48(1):28-33.
College: Harvard University, 1989, A.B. (Magna Cum Laude, Biology)
Medical School: University of Chicago Pritzker School of Medicine, 1994, M.D.
Internship: University of Chicago, Internal Medicine, 1994-1995, 1996-1998
Residency: University of California San Francisco, Anesthesiology, 1995-1996
Fellowship: University of California San Diego, Pulmonary and Critical Care Medicine, 1998-2001
Faculty at UCSD since 2001. Fellowship program director 2009-2017. Currently, Professor of Medicine in the Division of Pulmonary, Critical Care, Sleep Medicine, & Physiology. Section Chief of Pulmonary Vascular Medicine. Medical Director of Pulmonary Thromboendarterectomy Program.
Evaluation and treatment of pulmonary arterial hypertension
Interventional and medical management of chronic thromboembolic disease
Perioperative management following pulmonary thromboendarterectomy
Balloon pulmonary angioplasty for chronic thromboembolic disease
Clinical trials in pulmonary hypertension
As of Nov 2025: 132 peer-reviewed publications on pulmonary hypertension including, pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Lead author for the 5th, 6th, and 7th World Symposium on Pulmonary Hypertension task force on “Chronic Thromboembolic Pulmonary Hypertension”. 4th World Symposium on Pulmonary Hypertension task force member: “Endpoints and Clinical Trial Design in PAH” and “Interventional and Surgical Modalities of Treatment in PH”.
Master’s degree in Medicine from Seoul National University College of Medicine
Ph.D. in Medicine from Seoul National University College of Medicine
May. 2026~ Board of Director, Heart, ISHLT
May. 2025~ Associate director of ISHLT registry
July. 08. 2020 Research collaboration doctor at Mayo Clinic, Rochester, MN
July. 01. 2020 Director of Heart Transplantation, Incheon Sejong Hospital
April. 08. 2019 ~ June.08.2020 Visiting and Senior Research doctor at Mayo Clinic, Rochester, MN
March. 2017 ~ Director of Special Cardiac Imaging, Incheon Sejong General Hospital Director of Education and Research, Incheon Sejong General Hospital
Nov. 2015~ Director of Heart Transplantation Center, Sejong General Hospital
Nov. 2013 ~ Clinical physician Sejong General Hospital & Sejong Heart Institute, Korea
Heart Failure and Transplantation
Cardiac Genetics
Pulmonary Hypertension
Rare Cardiovascular Disease
Congenital Disease
Artificial intelligence-enabled electrocardiography in practice: a state-of-the-art review 2026/03/01
Inflammation and Heart Failure2026/04/01
Identification of recurrent MYH7 variant hypertrophic cardiomyopathy patient in Korea: a case series. 2025/12
Transparent and robust Artificial intelligence-driven Electrocardiogram model for Left Ventricular Systolic Dysfunction 2025/7/22
Electrocardiographic-Driven artificial intelligence Model: A new approach to predicting One-Year mortality in heart failure with reduced ejection fraction patients 2025/5/1
조선대학교 의과대학/의학전문대학원 교수
조선대학교 의과대학/의학전문대학원 학장 역임
조선대학교병원 심혈관센터장
전 서울대학교병원 임상강사
대한심장학회 정책이사 역임
International Society of Hypertension(ISH) 펠로우
한국고혈압관리협회 연구이사
대한고혈압학회 의료정보이사
대한혈관학회 이사
대한폐고혈압학회 이사
보건복지부 ‘지역심뇌혈관센터 지정기준’위원
질병관리청 ‘코로나 예방접종 이상반응 자문’위원 역임
통계청 ‘한국표준질병분류 자문’위원
건강보험심사평가원 ‘고혈압 전문분과’ 위원 역임
한국의약품안전관리원 ‘DUR 정보개발 자문’위원
한국의과대학협회 ‘미래의학 교육과정 개발 및 운영’위원
서울대학교병원 ‘심뇌혈관질환관리 국가통계 생산체계 운영사업’위원
고혈압(2020, 대한고혈압학회)
심부전(2020, 대한심부전학회)
고혈압 극복할 수 있다(2012, 한국고혈압관리협회)
노인의학 교과서 (2024, 대한노인병학회)
심전도 판독법(2006, 군자출판사)
Mar.2007- Feb 2009 Postgraduate School, Seoul National University, Seoul, Korea(Ph.D. in Medical Science)
Mar.2002-Feb. 2004 Postgraduate School, Seoul National University, Seoul, Korea(Master of Medical Science)
Mar.1995 -Feb.1999 College of Medicine, Seoul National University, Seoul, Korea(M.D.)
Mar. 1993-Feb.1995 Premedical Course, College of Liberal Arts & ScienceSeoul National University, Seoul, Korea
Mar.1990- Feb.1993 Seoul Science High School, Seoul, Korea
Sep.2023-present Director of Pulmonary Hypertension & Venous Thrombosis Center, Asan Medical Center, Seoul, Korea
Sep.2021-present Professor in Cardiology Asan Medical Center, Ulsan college of medicine, Seoul, Korea
Mar.2020-present Director of Echocardiography Laboratory, Asan Medical Center, Seoul, Korea
Apr.2015- Aug.2021 Associate professor in Cardiology Asan Medical Center, Ulsan college of medicine, Seoul, Korea
Feb.2016-Feb.2018 Research fellow, Harvard medical school, Massachusetts General Hospital, Boston, USA
Mar.2010-Mar.2015 Assistant professor in Cardiology Asan Medical Center, Ulsan college of medicine, Seoul, Korea
Mar.2009-Feb.2010 Clinical Fellowship in echocardiography & cardiac imagingAsan Medical Center, Seoul, Korea
May.2007-Feb.2009 Clinical Fellowship in general cardiology, Seoul National University Hospital, Seoul, Korea
Apr.2004- Apr.2007 Public Health Doctor Ministry of Health & Welfare, Korea
Mar.2000-Feb.2004 Residency in Internal medicine Seoul National University Hospital, Seoul, Korea
Mar.1999-Feb.2000 Internship, Seoul National University Hospital, Seoul, Korea
Echocardiography
Cardiac CT imaging
Valvular heart disease
Hypertension
Pulmonary arterial hypertension
(2009.3-2013.2) M.D. College of Medicine, Gachon university
(2021.3-2024.8) PhD, College of Medicine, Gachon university
(2013.3-2018.2) Internship & Resident, Department of Internal Medicine, Gachon University Gil Medical Center
(2018.3-2020.2) Clinical fellow, Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center
(2020.3-2021.2) Clinical fellow, Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital
(2021.3-2024.2) Clinical assistant professor, Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center
(2024.3-) Assistant professor, Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center
Chronic inflammatory disease/Systemic autoimmune disease
Yeo J, Kim JY, Kim MH, et al. Utility of the breath-holding test in patients with systemic sclerosis. Rheumatology (Oxford). 2022;61(10):4113-4118.
Yeo J, Park EA, Lee EB, et al. Angiographic characteristics of vasculopathy in patients with idiopathic inflammatory myopathies and systemic sclerosis. Sci Rep. 2022;12(1):9051.
Yeo J, Yoon SH, Kim JY, et al. Quantitative interstitial lung disease scores in idiopathic inflammatory myopathies: longitudinal changes and clinical implications. Rheumatology (Oxford). 2023;62(11):3690-3699.
Won Y, Yeo J, Jang Y, et al. Transition from parenteral treprostinil to selexipag aiming at hemodynamic targets in pulmonary arterial hypertension. Clin Hypertens. 2025;31(1):e5.
Yeo J, Kim MG K, Heo SY, et al. Dynamics of interleukin-23/interleukin-17 axis and type 1 regulatory T cells across disease stages in axial spondyloarthritis. Clin Exp Rheumatol. 2026.
MBBS, University of Queensland, 1996
BMedSc (with Distinction), Physiology and Pharmacology, University of Queensland, 1995
FRACP, Royal Australasian College of Physicians, 2005
Transplant and Pulmonary Hypertension Fellowship, The Prince Charles Hospital, 2005
Thoracic and Sleep Disorders Physician; Pulmonary Hypertension Specialist, 2005-Present
Lead Physician, Pulmonary Vascular Disease Unit/QLTS, The Prince Charles Hospital, 2015-Present
Director, Wesley Pulmonary Hypertension Unit, Wesley Hospital, 2008-Present
Director, Pulmonary Hypertension Research Queensland, 2025-present
President, Pulmonary Hypertension Society of Australia and New Zealand (PHSANZ), 2021-Present
Senior Lecturer in Medicine, University of Queensland, 2006–Present
Phase 1 to 4 Clinical Trials
Clinical trials in Groups 1 to 4
Exercise in PHT and exercise MRI
Kearney K et al. (incl. Feenstra J). Impact of left heart disease risk factors on outcomes in PAH therapy. Chest. 2024;165(4):967–977.
Feenstra J et al. Effectiveness of epoprostenol in PAH: findings of an Australian retrospective chart review. Intern Med J. 2020;50(11):1377–1384.
Anderson J et al. (incl. Feenstra J). Retrospective Validation of the REVEAL 2.0 Risk Score with the ANZ PH Registry. Chest. 2020;157(1):162–172.
Scalia GM et al. (incl. Feenstra J). ePLAR – echocardiographic pulmonary to left atrial ratio: a novel parameter to differentiate pre- and post-capillary PH. Int J Cardiol. 2016;212:379–386.
H-index: 10. ORCID: 0009-0006-2840-9272. Full publication list available on request.